News

  1. Home
  2. News

Flash News | Mabgeek Biotech Obtains Clinical Approval for EoE and PN Drugs

2024-09-27

Recently, the innovative monoclonal antibody drug "MG-K10 humanized monoclonal antibody injection" submitted by Mabgeek Biotech has obtained the drug clinical trial approval notice issued by the National Drug Evaluation Center. It is intended to be developed for the treatment of nodular prurigo (PN) and eosinophilic esophagitis (EoE). So far, MG-K10 humanized monoclonal antibody injection has obtained 5 drug clinical trial approval notices for indications.

picture

Source: CDE official website

All Rights Reserved by HUNAN MABGEEK BIOTECH CO., LTD  © 2018-2024 mabge.com

湘ICP备2024096314号 公安部备案：31011502015815

We use strictly necessary cookies to maintain an anonymous session and enable the website to function properly.
With your consent, we also use an analytics cookie to help keep article view counts accurate.
It prevents the same browser from repeatedly increasing an article's view count within a short period of time.
This analytics cookie is optional and will only be used if you consent.
You can change or withdraw your choice at any time through your Cookie Settings.
Agree Decline Cookie Settings

Cookie Settings

Necessary Cookies Used to maintain anonymous sessions and guarantee normal website operation, cannot be disabled. [Privacy Policy]  [Cookie Statement]
Close